Blood Cancer Institute Directors & Members

Working in a highly collaborative manner across Montefiore Einstein Comprehensive Cancer Center, global leaders in blood cancer research and care are driving advances in better understanding, preventing, and treating MDS, AML, and myriad other blood cancers. Much of the power of the Blood Cancer Institute derives from the multidisciplinary perspectives, insights, and tools that the members provide.

Blood Cancer Institute Directors

Under the leadership of Marina Konopleva, MD, PhD, Ulrich Steidl, MD, PhD, and Amit Verma, MD, the Blood Cancer Institute is making great strides in expanding treatment options for people with blood cancers.

Marina Konopleva, MD

Video could not be played

Marina Konopleva, MD

Co-Director, Translational Blood Cancer Institute, Montefiore Einstein Comprehensive Cancer Center
Ulrich G. Steidl, M.D., Ph.D.

Video could not be played

Ulrich G. Steidl, M.D., Ph.D.

Co-Director, Blood Cancer Institute
Amit K. Verma, MD

Video could not be played

Amit K. Verma, MD

Chair, Department of Oncology

Blood Cancer Institute Assistant Directors

BCI has appointed four Associate Directors to help shape the work and future BCI efforts in the area of basic and translational science. They will assist BCI leadership in fostering research collaborations, mentorship of junior faculty, educational activities, funding initiatives, and translation into novel clinical trials for our patients.

Teresa V. Bowman, Ph.D.

Video could not be played

Teresa V. Bowman, Ph.D.

Chair, Department of Developmental & Molecular Biology
Kira Gritsman, MD, PhD

Video could not be played

Kira Gritsman, MD, PhD

Assistant Director, Correlative Clinical Research
Aditi Shastri, MD

Video could not be played

Aditi Shastri, MD

Director, Myelodysplastic Syndromes and Clonal Hematopoiesis
Britta Will, Ph.D.

Video could not be played

Britta Will, Ph.D.

Director, Preclinical Modeling, Montefiore Einstein Comprehensive Cancer Center Blood Cancer Institute

Blood Cancer Institute Members

The more than 20 members of the Blood Cancer Institute help shape and drive basic and translational research in blood cancers.

Dennis L. Cooper, MD

Video could not be played

Dennis L. Cooper, MD

Director, Transplant and Cell Therapy
Eric J. Feldman, MD

Video could not be played

Eric J. Feldman, MD

Director, Early Phase Clinical Trials
David R. Fooksman, Ph.D.

Video could not be played

David R. Fooksman, Ph.D.

Professor, Department of Pathology
Mendel Goldfinger, MD

Video could not be played

Mendel Goldfinger, MD

Clinical Director, Blood Cancers
Keisuke Ito, M.D., Ph.D.

Video could not be played

Keisuke Ito, M.D., Ph.D.

Director of Scientific Resources of the Stem Cell Institute
Noah S. Kornblum, MD

Video could not be played

Ioannis Mantzaris, MD

Video could not be played

Ioannis Mantzaris, MD

Director, Leukemia Research
Maria Marianovich, Ph.D.

Video could not be played

Maria Marianovich, Ph.D.

Assistant Professor, Department of Cell Biology
Satish K. Nandakumar, M.B.,B.S., Ph.D.

Video could not be played

Satish K. Nandakumar, M.B.,B.S., Ph.D.

Assistant Professor, Department of Cell Biology
Yang Shi, MD, PhD

Video could not be played

Yang Shi, MD, PhD

Associate Professor, Department of Pathology
R. Alejandro A. Sica, MD

Video could not be played

R. Alejandro A. Sica, MD

Director, Solid Tumor Cell Therapies
Kristy R. Stengel, Ph.D.

Video could not be played

Kristy R. Stengel, Ph.D.

Melissa S. and John V. Ceriale Early Career Professorship
Yanhua Wang, MD, PhD

Video could not be played

Yanhua Wang, MD, PhD

Professor, Department of Pathology
B. Hilda Ye, Ph.D.

Video could not be played

B. Hilda Ye, Ph.D.

Professor, Department of Cell Biology